Expert Interview
Discussing the expanded approval of Jemperli (dostarlimab) plus chemotherapy for all adult patients with primary advanced or recurrent endometrial cancer, including MMRp/MSS tumors
Ticker(s): GSKSaketh R. Guntupalli, MD is Professor and Director of the Division of Gynecologic Oncology at the University of Colorado School of Medicine at Denver. In this role he leads one of the largest groups of physicians dedicated to women's cancer in the United States. He holds the Karen M. Jennison Endowed Chair in Gynecologic Oncology and also serves as Vice-Chair for Faculty Affairs and Development in the Department of OB-GYN
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
